GSI 1 (Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
Generic Name: cobicistat/elvitegravir/emtricitabine/tenofovir
Pill imprint GSI 1 has been identified as Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg.
Stribild is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GSI 1 (Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
- Generic Name:
- cobicistat/elvitegravir/emtricitabine/tenofovir
- Imprint:
-
GSI
1 - Strength:
- cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg
- Color:
- Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Gilead Sciences, Inc.
More resources
Stribild is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
